Growth Metrics

Uxin (UXIN) Current Deferred Revenue (2017 - 2025)

Uxin filings provide 9 years of Current Deferred Revenue readings, the most recent being $7.4 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 98.52% to $7.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.4 million, a 98.52% increase, with the full-year FY2025 number at $7.4 million, up 98.52% from a year prior.
  • Current Deferred Revenue hit $7.4 million in Q4 2025 for Uxin, up from $3.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $7.4 million in Q4 2025 to a low of $2.0 million in Q1 2024.
  • Median Current Deferred Revenue over the past 5 years was $3.2 million (2022), compared with a mean of $3.6 million.
  • Biggest five-year swings in Current Deferred Revenue: crashed 50.18% in 2021 and later skyrocketed 98.52% in 2025.
  • Uxin's Current Deferred Revenue stood at $3.6 million in 2021, then decreased by 20.87% to $2.8 million in 2022, then decreased by 28.51% to $2.0 million in 2023, then soared by 83.02% to $3.7 million in 2024, then skyrocketed by 98.52% to $7.4 million in 2025.
  • The last three reported values for Current Deferred Revenue were $7.4 million (Q4 2025), $3.7 million (Q4 2024), and $2.0 million (Q1 2024) per Business Quant data.